TG6002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TG6002, covering 2017-11-06 to 2017-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients [Phase 1, Phase 2]